S-1 · primary offering
Issued 2020
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 39 of ALX ONCOLOGY HOLDINGS INC's SEC filings and found 3 warrant series, 1 ATM program, 3 shelf registrations, 2 S-1 registrations and 2 completed offerings on file for ALXO. The latest dilution event on file is an agreed share issuance on Oct 14, 2026. Analysis updated Oct 21, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 20 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Oct 14, 2026 · Issuance Agreed
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2020
Proposed maximum
Shares registered
Proposed maximum
Shares registered
Issued 2023
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2021
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Issued 2022
Total capacity
Remaining
Issued 2023
Total capacity
Remaining
Issued 2026
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z